This site is intended for healthcare professionals only
LoginRegister
DoP Notifies Rs 5000 Cr PRIP Scheme to Boost Pharma, MedTech R&DNo Life-Saving Drug Category In India, Govt Clarifies as 930 Medicines Remain Under Price Control
CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR DataCDSCO Panel Accepts Glenmark's Apremilast Trial Report, Seeks 2-Year PSUR Data
Sun PharmaSun Pharma Gets CDSCO Panel Nod For Alfuzosin-Tadalafil FDC Post-Marketing Study
Boehringer Ingelheim Jascayd tablets approved by USFDA for idiopathic pulmonary fibrosisBoehringer, Click Therapeutics investigational prescription digital therapeutic meets primary...
AMC Flags Human Trial Violations, Refers Case to Gujarat FDCAAbiogenesis Clinpharm To Conduct Phase III Trial of UTI Drug Phenazopyridine
Goa unveils lifesaving therapies pricing policyLaborate Pharma secures EU-GMP certification, expands global supply chain capabilities
NPPA Clarifies Pharma Data Tender Terms, Technical Presentations on Sept 19Indian pharma market registers 7.9 percent growth in July: Report
Aragen appoints Aniel KhubchandaniAragen appoints Aniel Khubchandani as CEO of Development and Manufacturing Solutions business
EMA Committee approves update to Novo Nordisk Rybelsus label to reflect cardiovascular benefitsMounjaro, Wegovy sales in India double on month in July
Eli Lilly Inluriyo gets USFDA nod for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancerEli Lilly Gets CDSCO Panel Nod for Ixekizumab Safety Label Update
Novo NordiskCDSCO Panel Approves New Indications for Novo Nordisk's Semaglutide, Mandates PMS Study
Intas Pharma Told to Revise Phase I, III Pembrolizumab Trial ProtocolIntas Pharma Gets Expert Panel Nod For PMS Data On Tofacitinib Ointment In Atopic Dermatitis
X